NASDAQ:GYRE | Free Cash Flow | GYRE THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$3.18M$178,000.00$3M
2025-12-31-$5.63M$144,000.00-$5.77M
2025-03-31-$129,000.00$122,000.00-$251,000.00-5.08%
2024-12-31-$2.76M-$65,000.00-$2.82M-472.07%
2024-03-31$2.88M$231,000.00$2.65M26.70%
2023-12-31$3.36M$2.32M$1.04M
2023-03-31$10.42M$1.74M$8.68M205.71%
2022-12-31$42.3M
2022-03-31-$12.05M
2021-12-31-$17.68M$0.00-$17.68M
2021-03-31-$24.36M
2020-12-31-$22.11M
2020-03-31-$4.79M$17,000.00-$4.81M
2019-12-31-$8.09M-$1,000.00-$8.09M
2019-03-31-$14.96M$15,000.00-$14.97M
2018-12-31-$9.01M$175,000.00-$9.19M
2018-03-31-$5.11M$198,000.00-$5.31M
2017-12-31-$6.32M$20,000.00-$6.34M
2017-03-31-$4.29M$3,000.00-$4.3M
2016-12-31-$4.98M$122,000.00-$5.1M
2016-03-31-$4.74M$89,000.00-$4.83M
2015-12-31-$5.14M$98,000.00-$5.24M
2015-03-31-$2.98M
2014-12-31-$2.06M$0.00-$2.06M
2014-03-31-$14.85M
2013-12-31-$11.17M-$51,000.00-$11.22M-48.00%
2013-03-31-$9.32M$70,000.00-$9.39M
2012-12-31-$11.6M$195,000.00-$11.8M
2012-03-31-$24.9M$46,000.00-$24.95M-1104.29%
2011-12-31-$20.53M$252,000.00-$20.78M
2011-03-31-$22.05M$598,000.00-$22.64M-179.89%
2010-12-31-$15.71M$1.61M-$17.33M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.01M$1.19M-$180,000.00-1.82%
2024-12-31-$3.64M$2.32M-$5.96M-33.28%
2023-12-31$25.89M$8.52M$17.38M
2022-12-31$10.68M$4.99M$5.69M131.94%
2021-12-31-$83.76M$839,000.00-$84.59M
2020-12-31-$55.05M
2019-12-31-$43.61M$64,000.00-$43.68M
2018-12-31-$28.55M$376,000.00-$28.93M
2017-12-31-$19.94M$23,000.00-$19.96M
2016-12-31-$18.47M$468,000.00-$18.94M
2015-12-31-$19.12M$272,000.00-$19.39M
2014-12-31-$6.39M$4,000.00-$6.39M
2013-12-31-$40.61M$41,000.00-$40.65M
2012-12-31-$64.24M$333,000.00-$64.57M
2011-12-31-$83.72M$1.43M-$85.15M
2010-12-31$138.3M$3.31M$134.99M1238.53%
2009-12-31-$24.27M$200,000.00-$24.47M